Peer-reviewedLicence not statedVirulence
Genomic insights into multidrug-resistant bacteria: Emergence of mcr-1.1 in Escherichia coli , bla KPC-2 in Klebsiella pneumoniae and Serratia marcescens from clinical settings
- 1Guangdong Med-Max Medical Lab Co., Ltd
- 2Yangzhou University
Related
- Genomics of multidrug-resistant Klebsiella pneumoniae isolates from community hospitals in Pretoria, South Africa
- Optimized alkyne-modified pyridylpiperazine efflux pump inhibitors overcome intrinsic macrolide resistance in multidrug-resistant Klebsiella pneumoniae isolates
- In Vitro Activity of Imipenem/Relebactam and Ceftolozane/Tazobactam Against Multidrug-Resistant Klebsiella pneumoniae: A Retrospective Single-Center Study in China.
- L-histidine metabolic reprogramming is associated with imipenem-relebactam resistance in carbapenem-resistant hypervirulent Klebsiella pneumoniae
- Phytochemical screening as an inhibitor of β-lactamases to overcome the carbapenem-resistant of Klebsiella pneumoniae
BibTeX
@article{hameed2026genomic,
title = {{Genomic insights into multidrug-resistant bacteria: Emergence of mcr-1.1 in Escherichia coli , bla KPC-2 in Klebsiella pneumoniae and Serratia marcescens from clinical settings}},
author = {Muhammad Fazal Hameed and Muhammad Shoaib and Kai Peng and Z G Wang and Ruichao Li},
journal = {Virulence},
year = {2026},
month = may,
doi = {10.1080/21505594.2026.2668179},
url = {https://doi.org/10.1080/21505594.2026.2668179},
}
RIS
TY - JOUR
TI - Genomic insights into multidrug-resistant bacteria: Emergence of mcr-1.1 in Escherichia coli , bla KPC-2 in Klebsiella pneumoniae and Serratia marcescens from clinical settings
AU - Muhammad Fazal Hameed
AU - Muhammad Shoaib
AU - Kai Peng
AU - Z G Wang
AU - Ruichao Li
PY - 2026
DA - 2026/05/08
JO - Virulence
DO - 10.1080/21505594.2026.2668179
UR - https://doi.org/10.1080/21505594.2026.2668179
SN - 2150-5594
SN - 2150-5608
ER -